Bonfigli, A R <br/><br/>
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients.  [electronic resource] 

 -  Nutrition, metabolism, and cardiovascular diseases : NMCD  10 2016 
 - 893-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1590-3729 
<br/><br/><label>Standard No.: </label>10.1016/j.numecd.2016.06.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Amoxicillin--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Biomarkers--blood<br/>Blood Glucose--metabolism<br/>Clarithromycin--administration & dosage<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Esomeprazole--administration & dosage<br/>Female<br/>Helicobacter Infections--blood<br/>Helicobacter pylori--drug effects<br/>Homeostasis<br/>Host-Pathogen Interactions<br/>Humans<br/>Inflammation Mediators--blood<br/>Insulin--blood<br/>Insulin Resistance<br/>Italy<br/>Male<br/>Middle Aged<br/>Proton Pump Inhibitors--administration & dosage<br/>Time Factors<br/>Treatment Outcome